Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study
Title:
Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study
Author:
Khurana, Sandhya Brusselle, Guy G. Bel, Elisabeth H. FitzGerald, J. Mark Masoli, Matthew Korn, Stephanie Kato, Motokazu Albers, Frank C. Bradford, Eric S. Gilson, Martyn J. Price, Robert G. Humbert, Marc